Drug Discovery & Repurposing Services to Pharma Companies & Therapeutic Guidelines Support to Oncologists
Neozenome employs a unique AI/ML based drug discovery / target identification / disease prediction platforms for offering related services to drug manufacturing companies enabling them to fast track their drug discovery initiatives.
It also leverages integrated molecular profiling technologies for offering services to oncologists enabling them to make intelligent decisions on drug choices for a given disease condition.
AI/ML Based Services
Neozenome leverages AI / ML based platforms / tools to fast track service delivery, no matter how complex the problem scenarios may be.
Deep Disease-Biology Services
Neozenome is not just a technology player but a strong domain expert in cancer biology, always ensuring high quality service delivery.
Neozenome implements its offshore delivery model to ensure physicians or drug manufacturers get their services delivered at least possible cost.